Evidence map›Paper›PMID 37764687›Full record

ReviewNutrients2023

Possible Mechanisms of Dark Tea in Cancer Prevention and Management: A Comprehensive Review.

Huilin Deng, Jia Liu, Ying Xiao, Jian-Lin Wu, Rui Jiao

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Defense against oxidative stress inFrontiers in veterinary science · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Huilin DengDepartment of Food Science and Engineering, Institute of Science and Technology, Jinan University, 601 Huangpu Road, Guangzhou 510632, China.
Jia LiuDepartment of Food Science and Engineering, Institute of Science and Technology, Jinan University, 601 Huangpu Road, Guangzhou 510632, China.
Ying XiaoFaculty of Medicine, Macau University of Science and Technology, Macau, China.
Jian-Lin WuState Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China.
Rui JiaoDepartment of Food Science and Engineering, Institute of Science and Technology, Jinan University, 601 Huangpu Road, Guangzhou 510632, China.
Jinan University · CNMacau University of Science and Technology · MO

Funding

the National Natural Science Foundation of China No.32272310the Science and Technology Development Fund, Macau SAR No. FDCT 0067/2020/A2
6 · The paper itself

Abstract

Tea is one of the most popular drinks in the world. Dark tea is a kind of post-fermented tea with unique sensory characteristics that is produced by the special fermentation of microorganisms. It contains many bioactive substances, such as tea polyphenols, theabrownin, tea polysaccharides, etc., which have been reported to be beneficial to human health. This paper reviewed the latest research on dark tea's potential in preventing and managing cancer, and the mechanisms mainly involved anti-oxidation, anti-inflammation, inhibiting cancer cell proliferation, inducing cancer cell apoptosis, inhibiting tumor metastasis, and regulating intestinal flora. The purpose of this review is to accumulate evidence on the anti-cancer effects of dark tea, the corresponding mechanisms and limitations of dark tea for cancer prevention and management, the future prospects, and demanding questions about dark tea's possible contributions as an anti-cancer adjuvant.

Indexed as

Adjuvants, ImmunologicNeoplasmsApoptosisCell ProliferationFermentationHumansTeaAdjuvants, ImmunologicTeaanti-cancerdark teadietary adviceMAPK/JNKNF-κBtea polyphenolstea polysaccharidetheabrownin

Identifiers

PMID37764687
PMCPMC10534731
OpenAlexW4386496218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.